Background. Melioidosis results from infection with Burkholderia pseudomallei and is associated with casefatality rates up to 40%. Early diagnosis and treatment with appropriate antimicrobials can improve survival rates. Fatal and nonfatal melioidosis cases were identified in Puerto Rico in 2010 and 2012, respectively, which prompted contact investigations to identify risk factors for infection and evaluate endemicity.
Melioidosis is an acute febrile illness resulting from infection with the gram-negative bacillus Burkholderia pseudomallei, and can have case-fatality rates as high as 40% [1] . Clinical presentations range from skin or soft tissue abscesses to fulminant septicemia, although the most common presentation is acute pneumonia with or without septicemia [1, 2] . Up to 80% of patients with melioidosis have 1 or more risk factors for illness, including diabetes, excessive alcohol use, and chronic lung disease [3] . Melioidosis should be considered an opportunistic pathogen in persons with these conditions. Improved survival rates are attributed to access to care, early diagnosis, and treatment with appropriate antimicrobials [3] . Although B. pseudomallei grows readily in commercially available blood culture media, it is not unusual for laboratory staff to misidentify the bacteria [4, 5] or dismiss positive results as a culture contaminant [6] .
Individuals in regular contact with soil or water harboring B. pseudomallei are at highest risk for acquiring melioidosis [1] . The primary routes of infection are percutaneous inoculation, ingestion, and inhalation; person-to-person transmission is rare [2, 7] . Melioidosis is considered to be highly endemic in northeast Thailand, Malaysia, Singapore, and northern Australia; endemic throughout much of south-central and maritime Southeast Asia; and sporadic in Africa and Latin America, including the Caribbean basin [8] .
Three locally acquired cases of melioidosis were reported from the United States territory of Puerto Rico in 1982 [9] , 1998 [10] , and 2003 [11] (Table 1) . In 2009, a fourth case occurred in a resident of Puerto Rico who sought medical care in Florida due to fever, cough, and anorexia (Centers for Disease Control and Prevention [CDC] and Florida Department of Health, unpublished data, 2009). All 4 patients were residents of the eastern side of the island. In the 3 prior Puerto Rican cases for which multilocus sequence typing (MLST) results were available, either sequence type 297 (ST297) or a single-or double-locus variant of ST297 was identified [12] . All 3 patient B. pseudomallei isolates were determined to be type G using internal transcriber spacer (ITS) typing. B. pseudomallei isolates from the Western Hemisphere are consistently type G [12] .
Following identification of melioidosis cases in 2010 and 2012, an investigation was conducted to describe the patients' illnesses, determine location of exposure (ie, home vs work), identify risk factors for infection, and conduct environmental sampling to isolate B. pseudomallei from soil.
METHODS
In November 2012, the Puerto Rico Department of Health and the CDC investigated the melioidosis cases from 2010 and 2012. To assess possible risk factors for exposure to B. pseudomallei and development of melioidosis, a standardized questionnaire was developed that collected information on demographics, behavioral practices, and medical histories. The exposure period for investigation participants was the month prior to and the 2 months after the onset of illness of the 2010 and 2012 patients for each respective exposure location. Serum specimens were collected from consenting household contacts and coworkers of each case for detection of anti-B. pseudomallei antibody by indirect hemagglutination assay (IHA); seropositivity was defined by an IHA titer ≥1:40 [13] . In December 2012, the investigation was expanded to include a 250 meter sampling radius around each patient's household. Although all households within this radius were visited during investigation of the 2010 case, only 1 in 3 houses within this radius were visited during investigation of the 2012 case due to high household density. Clusters of 3 households were designated, and the first household with an available respondent in each cluster was offered participation.
Households that declined participation were not replaced. Verbal informed consent was obtained from individuals ≥18 years of age or from the parent or guardian of individuals <18 years of age. Verbal assent was obtained from children ≥7 years of age. Questionnaires were administered verbally to participants, and parents provided responses for children <7 years of age. Despite no direct links to the patient, a health fair was conducted to include local injection drug users (IDUs) who frequented the same injection drug locale reported by the 2012 patient.
In November 2013, soil samples were collected from various sites within the 250 meter radius of the 2012 patient's residence and injection drug use sites. Sampling areas were selected for their proximity to residences of seropositive individuals identified through the serosurvey, or by location of injection drug use where IDUs could have been exposed to soil or water. Specific locations within each sampling area were chosen based on soils with pH between 4.5 and 6.0 as identified from the US Department of Agriculture's Web soil survey [14] . Soil samples were not collected using a grid method due to steep terrain and dense vegetation. Soil collection followed existing guidelines with 40-60 g of soil collected at a depth of approximately 30 cm [15] .
Isolation of B. pseudomallei in soil samples was based on accepted methodology [15] . Ten grams of soil was mixed with 10 mL of selective broth (Threonine-basal salt solution with colistin 50 mg/L), and incubated at 40°C for 48 hours. Ten microliters from the top layer was plated onto Ashdown agar plates, streaked for isolation, and incubated at 40°C for 7 days, and plates were examined for colonies every 24 hours. Colonies exhibiting morphology consistent with B. pseudomallei were confirmed using the Laboratory Response Network's testing algorithm for the identification of B. pseudomallei (biochemical testing and realtime polymerase chain reaction [PCR]). Analysis by MLST and ITS typing was performed as previously described [16] [17] [18] .
Odds ratios with 95% confidence intervals were calculated using logistic regression to test for association between seropositivity and characteristics of the individuals tested. Characteristics significantly associated with seropositivity in the univariate analysis were further assessed by using multivariable logistic regression models using SAS version 9.3 (SAS Institute, Cary, North Carolina). Spatial analysis of seropositive and seronegative individuals was conducted using R version 3.0.0 [19] and SaTScan version 9.2 [20] to assess spatial clustering.
RESULTS

Case Reports
Case 1
In December 2010, a 38-year-old male groundskeeper from Carolina, located in northeastern Puerto Rico, presented to an emergency services clinic due to a 5-day history of back pain, fever, and weakness. On presentation, he was ashen in polyclonal antibody raised against B. pseudomallei. Gram typespecific pan-eubacteria PCR was positive for Burkholderia species, and sequencing revealed a closest match with B. pseudomallei. MLST was performed on DNA extracted from tissue specimens, and 6 of 7 alleles matched ST297; 1 locus failed to amplify.
Case 2
In October 2012, a 60-year-old unemployed man from Maunabo, located in southeastern Puerto Rico, presented to an emergency room with a 3-day history of nausea, vomiting, anorexia, and abdominal and chest pain. Other relevant health history included diabetes mellitus, obesity (BMI = 33.6 kg/m 2 ), hypertension, cellulitis, abscesses, schizophrenia, alcohol use, and smoking. He had previously worked on a farm in New Jersey and at a coffee-packing plant in Pennsylvania from the late 1970s through the mid-1990s, and part-time on a banana farm in Maunabo in the months before illness onset. He reported intermittent intravenous use of heroin and cocaine and had last injected roughly 1 week before illness onset. Upon presentation, the patient was afebrile, anorexic, and had abdominal pain and hematuria. Laboratory results revealed hyperglycemia (glucose = 457 mg/dL), leukocytosis (WBC = 16 370 cells/µL), neutrophilia (84.8%), and decreased arterial blood pH (7.31; normal range, 7.38-7.42). He was given oxygen by rebreather mask, intravenous 0.9% saline and amoxicillin-cloxacillin (400 mg every 24 hours), and oral acetaminophen. He was transferred to a referral hospital with a diagnosis of diabetic ketoacidosis. While awaiting transfer, he became febrile (temperature = 38.7°C; normal: 37°C), hypertensive (BP = 160/100 mm Hg), tachycardic ( pulse = 118 beats/ minute; normal range, 60-100 beats/minute), and tachypneic (respiratory rate = 24 breaths/minute).
After arrival at the referral hospital, the patient was afebrile but continued to be hypertensive and hyperglycemic, both of which persisted throughout hospitalization. He became alkalotic ( pH = 7.44), and CBC revealed thrombocytopenia ( platelets = 132 000/µL) and persistent neutrophilia (90%). Chest radiography showed a mildly enlarged heart. Two days later, the patient became mildly disoriented and blood culture results were positive for growth of gram-negative bacilli; antimicrobial treatment was changed to intravenous cefepime hydrochloride (2 g every 12 hours). After 48 hours of incubation, B. pseudomallei was identified. Results were confirmed at CDC with MLST identified as ST297 and ITS typing as a type G isolate. The organism demonstrated susceptibility to amoxicillinclavulanic acid, ceftazidime, doxycycline, imipenem, tetracycline, and trimethoprim-sulfamethoxazole (TMP-SMX).
The patient completed 10 days of intravenous antimicrobial therapy and was discharged after an uneventful hospitalization. Blood culture taken on day 10 had no bacterial growth after 72 hours of incubation. He was prescribed oral TMP-SMX for 3 months. Available acute serum from 4 days after admission showed a B. pseudomallei IHA titer of 1:320. Convalescent serum taken 10 days after discharge had an IHA titer of 1:640.
Serosurvey
During the investigation, 51 serum specimens and questionnaires were collected from the 2010 patient's household and work contacts. All coworkers were seronegative, whereas 1 household contact was seropositive (Table 2) . A total of 17 of 44 (39%) households within a 250 meter radius of the patient's residence participated in the investigation. Of 40 neighbors who provided a serum specimen, 2 (5%) were seropositive. Overall, 6% of the 2010 patient's contacts tested were seropositive. Similarly, 60 serum specimens and questionnaires were collected from the 2012 patient's household, work, and IDU contacts. The patient's sole coworker was seronegative, and 1 household member was seropositive. After random selection of one-third of houses within a 250 meter radius of the patient's residence, 28 of 32 (88%) households participated in the investigation. Of 52 neighbors who provided a serum specimen, 12 (23%) were seropositive. Among 3 IDU contacts, 2 (67%) were seropositive. Overall, 25% of the 2012 patient's contacts tested were seropositive.
Spatial Analysis
Mapping of the households of seropositive contacts of the 2010 patient demonstrated that 2 households located south of the patient's household each had 1 seropositive household member (data not shown). For the 2012 case, mapping demonstrated that all other seropositive contacts' households were located southeast of the patient's household; 1 household contained 2 seropositive household members, and 2 households contained 3 seropositive household members (Figure 2 ). Cluster analysis via SaTScan did not reveal evidence of significant spatial clustering of either seropositive or seronegative individuals within the study areas surrounding either site.
Soil Sampling
Of 20 soil samples collected in the neighborhood of the 2012 patient's residence, 2 isolates of B. pseudomallei were recovered from multiple extractions of a single soil sample taken near a household with 2 seropositive household members (Figure 2) . Analysis by MLST indicated that both soil colonies were Abbreviations: CI, confidence interval; OR, odds ratio. a All participants who did not provide a blood specimen for serodiagnostics to be performed were excluded from analysis.
b Odds ratio calculated for age in years using logistic regression.
c Carpenter, construction worker, equipment operator, industrial welder, mechanic, maintenance worker, patio cleaner, and janitor.
d Teacher, merchant, office worker, supervisor, school lunchroom worker, policeman, surgery technician, nurse, secretary, and restaurant worker.
e Alopecia, anemia, appendicitis, arthritis, breast cysts, high blood pressure, cleft palate, dermatitis, epilepsy, glaucoma, pancreatitis, heart murmur, hypercholesterolemia, hyperthyroidism, hypothyroidism, migraine, neuralgia, pancreatic nodules, osteoporosis, and/or sinusitis.
ST297 as well as type G by ITS typing. Burkholderia pseudomallei was not isolated from any of the 6 soil samples taken at the site where the 2012 patient reported injection drug use.
Data Analysis
Among all investigation participants, nearly all (97%) selfidentified as Hispanic; half were male, median age was 47 years (range, 3-88 years), and few (11%) reported agricultural work (Table 3) . No demographic characteristics or individual employment categories were significantly associated with being seropositive. Seven of 18 (39%) seropositive contacts reported never having traveled outside of Puerto Rico. No medical conditions were significantly associated with being seropositive. Reporting having skin wounds, sores, or ulcers and history of current or past illicit drug use, specifically cocaine and injection drug use, were significantly associated with seropositivity. Reporting having skin wounds, sores, or ulcers and history of current or past injection drug use remained significant following multivariable logistic regression analysis (Table 4) .
DISCUSSION
All patients with melioidosis identified in Puerto Rico prior to this investigation resided in eastern Puerto Rico, and ST297 or a single-or double-locus variant of ST297 was identified in the 3 isolates for which MLST results were available (Table 1) . In this investigation, B. pseudomallei from the 2010 patient's tissue was identified as a single-locus variant of ST297 (Table 1 ). The B. pseudomallei isolated from the 2012 case patient's serum and a soil sample from the 2012 patient's neighborhood were identified as ST297. Scientific literature documents most ST297
isolates to Puerto Rico [12] . Further, serosurveys showed rates of seropositivity of 6% and 25%, and more than one-third of seropositive individuals reported never having traveled outside of Puerto Rico. Taken together, these findings demonstrate endemicity of B. pseudomallei in eastern Puerto Rico.
Seropositivity for B. pseudomallei in this investigation was associated with 2 risk factors: history of skin wounds, ulcers, or sores, which are known to be common routes of B. pseudomallei infection; and history of injection drug use, which can provide entry points for infection with B. pseudomallei contaminants arising from lack of antiseptic procedures during injection [1, 2] . Injection drug use has not been associated with B. pseudomallei infection since melioidosis was first described in morphine addicts in Burma in 1913 [21] . Future investigations should further explore and better define the relationship between injection drug use and infection with B. pseudomallei infection in Puerto Rico and other regions with endemic melioidosis, as previous studies may not have included such individuals. Despite presumed common exposure through outdoor employment, none of the patients' coworkers had evidence of exposure; however, multiple residential contacts were seropositive, suggesting exposure at or near home rather than the workplace.
Although the median incubation period of B. pseudomallei is 9 days, it is well documented that illness can occur years after exposure [22] . Reactivation from a latent focus of B. pseudomallei infection has been associated with roughly 4% of symptomatic melioidosis cases and has also been associated with episodes of diabetic ketoacidosis [3, 23] . The 2012 patient could have had a recent infection, perhaps associated with his most recent injection drug use 1 week before illness onset, or Abbreviations: CI, confidence interval; OR, odds ratio. a All participants who did not provide a blood specimen for serodiagnostics were excluded from analysis.
b All values shown in bold indicate a significant difference (P < .05).
he may have been experiencing reactivation from a latent infection. Although drug susceptibility testing for cefepime was not performed and neither cefepime nor amoxicillin-cloxacillin is known to be efficacious against B. pseudomallei, this patient responded to treatment with these drugs. Nonetheless, the recommended intravenous antimicrobials for treatment of melioidosis are ceftazidime, meropenem, and imipenem [1] . To our knowledge, our investigation was the first to conduct serosurveys within the Caribbean for this underrecognized disease. We also demonstrated the first published isolation of B. pseudomallei from soil in Puerto Rico. Nonetheless, this investigation was subject to several limitations. First, interpretation of results from the investigation of the 2010 case could have been limited by recall bias, as participants were queried regarding events that had occurred 3 years earlier. Also, the association of seropositivity with injection drug use was based on a small sample size. Thus, these findings should be further explored.
Due to the demonstrated endemicity of B. pseudomallei in eastern Puerto Rico, the public should be made aware of this pathogen. Specifically, individuals with diabetes, who are at higher risk for developing melioidosis, should be advised to protect themselves from direct exposure to soil and water, the natural habitat of B. pseudomallei, to reduce their likelihood of infection [4] . Moreover, clinicians should be made aware of the presence of melioidosis in Puerto Rico, which should be considered in patients with community-acquired pneumonia, skin infections, and septicemia, especially in diabetic patients with a history of soil or water exposure. Clinical diagnostic laboratories should fully identify cultures of gram-negative rods to rule out B. pseudomallei. Increased awareness among clinicians and laboratories could aid in identification of future cases and prompt initiation of appropriate antibiotic therapy, which could in turn reduce additional morbidity and mortality due to melioidosis in Puerto Rico.
Notes
